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thrombus was created in the mid-LAD of 25 dogs. Risk area (RA) was measurgd using 
myocardial contrast echocardiography. Percutaneous transluminal coronary angioplasty 
(PTCA) was performed 2 hr later and successful recanalization was confirmed. A novel 
compound (CP4715, Meiji) that inhibits both llblllla and a,& was administered in 9 dogs 
(Group 1) 10 min before PTCA and for 3 hr thereafter. Groups 2 and 3 dogs received 
either Ilb/llla antagonist (tirofiban, n=9) or normal saline (controls, n=7). 9s~c-labeled 
platelet glycoprotein Ilb/llla inhibitor (DMP444. Bristol Myers Squibb Medical Group) was 
used to determine platelet aggregation within the RA. Microbubbles conjugated to 
echistatin were administered to measure aJ3, inhibition. IS was determined using post- 
mortem triphenyltetrazolium chloride staining. Results RA (% of lefl ventricular cross 
sectional area) was similar in all 3 groups (44+7. 41+13. and 43+11). The IS/RA ratio 
was smallest in Group 1 and largest in Group 3 (24+12,37+15. and 59*13). There was a 
59% decrease in IS by CP4715 compared to controls (pqO.01) end 35% reduction com- 
pared to tirofiban (PcO.05). 99mTc activity was similar in Groups 1 and 2 dogs and signifi- 
cantly lower (~~0.05) than Group 3 (1.6*0.4, 1.7a0.3, and 2.721 .O) indicating substantial 
Ilb/llla inhibition by CP4715 or tirofiban. Signal from schistatin conjugated microbubbles 
was the lowest (~~0.05) in Group 1 (60331, 118t37, and 111+36) indicating +Ss antag- 
onism by CP4715. Conclusions Dual antagonism of llb/llla and a& caused a marked 
reduction in IS. which was greater than a decrease in IS by Ilb/llla antagonism alone. 
Thus, combined inhibition of both Ilb/llla and 2135 may have an important role in reduc- 
ing IS during acute coronary thrombosis. 
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1025A-MP-205 Insulin Reduces Myocardial Flow Heterogeneity During 
Reperfusion 
Xuedono Shen, Huagui Li, Feng Xie, Thomas R. Porter, John Lol, Leng Jiang, The 
Cardiac Center of Creighton University, University of Nebraska Medical Center, Omaha, 
NE, Baystate Medical Center, Springfield, MA 
We have demonstrated that insulin improves myccardial microcirculation after acute 
ischemia with hyperglycemia (HG) using power pulse inversion imaging (PPI) and Neu- 
tron Activated Microspheres (MIC). The myocardial flow heterogeneity (FH) reflects the 
perfusion distribution. We hypothesized that insulin can reduce FH. Six dogs were stud- 
ied by using myocardial contrast echocardiography during a continuous intravenous infu- 
sion of perflurocarbon exposed sonicated dextrose albumin microbubbles. The study 
included 3 sequential stages: 1) myocardial &hernia produced by ligation of left anterior 
descending coronary artery, 2) reperfusion (RP) with HG produced by glucose injection 
(plasma concentration of 407t 54mg/dl), 3) reperfusion with HG and after insulin intrave- 
nous injection. Lefl ventricle was imaged on short-axis at mid-papillary muscle level. 
lschemic and non-ischemic (IR, NIR) regional myocardial blood flow (MBF) was esti- 
mated and FH was defined as SD/mean MBF*lOO%. MIC was used for validation. 
Results: 1) There was no change from stage 1 to 3 in diastolic aortic pressure, heart rate 
and left ventricular end-diastolic pressure (~~-0.05). 2) PPI-derived MBF correlated well 
with MIC-MBF (rE0.91, p<O.OOOl). 3) During stage 1, FH was 81.3% in IR, 69.9% in NIR. 
4) During stage 2, FH mildly worsened in IR (87.9%. p=O.ll), and significantly deterio- 
rated in NIR (117.6%, p=O.Ol). 5) During stage 3, FH significantly Improved both in IR 
49.3%, p=O.O06) and in NIR (38.2%. p=O.O002). 
Conclusion: Insulin reduces myocardial flow helerogeneity during reperfusion when 
hyperglycemia is present, suggesting the benefit of intensive insulin therapy for diabetic 
patients during acute ischemia and reperfusion. 
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1025A-MP-206 Quantitative Intravenous Myocardial Contrast 
Echocardioaraohv Predicts Recoverv of Left Ventricular _ . - 
Function After Revascularization In Chronic Coronary 
Artery Disease 
Shota Fukuda Takeshi Hozumi, Takashi Mum. Hiroyuki Watanabe, Eiichi Hyodo, Minoru 
Yoshiyama, Kazuhide Takeuchi, Junichi Yoshikawa. Osaka City University School of 
Medicine, Osaka, Japan 
Background. Quantitative intravenous myocardial contrast echocardiography (MCE) 
has been shown to measure regional myocardial blood flow velocity noninvasively. The 
purpose of this study is lo determine whether quantitative intravenous MCE can be used 
clinically to predict functional recovery after revascularization in patients with chronic cor- 
onary artery disease. 
Methods. Twenty-eight patients with chronic stable coronary artery disease and resting 
regional IefI ventricular dysfunction were included in this study. The study permits myo- 
cardial perfusion analysis by intravenous MCE before revascularization with continuous 
infusion of Levovist and intermittent ultrasonic exposure. Wall motion assessment by 
echocardiography at rest was repeated after long-term follow-up period (7+2 months). In 
dysfunctional segments, we analyzed myocardial perfusion quantitatively by fitting to an 
exponential function, Y=A(l-em@) to obtain the rate of rise (p) of background-subtracted 
intensity which represented myocardial blood flow velocity. Results. of 101 revascular- 
ized dysfunctional segments. MCE was adequately visualized in 91 (90%) segments, 
and wall motion was recovered in 45 (49%) segments. The value of p in recovery seg- 
ments was significantly higher than that in non-recovery segments (0.80*0.50 vs. 
0.39*0.24, p<O.OOl). The value of p aO.5 predicted recovery of segmental function with a 
sensitivity of 71%, specificity of 78%. Conclusion. Quantitative intravenous MCE can 
predict functional recovery after revascularization in patients with chronic coronary artery 
disease. 
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1025A-MP-207lntravenous Versus lntracoronary Myocardial Contrast 
Echocardiography for the Evaluation of No-Reflow After 
Primary Coronary Angioplasty 
Jona-Min Song, Jae-Hwan Lee, Young-Hak Kim, Duk-Hyun Kang, Jae-Kwan Song, 
Myeong-Ki Hong, Seong-Wook Park, Seung-Jung Park, Asan Medical Center. Seoul, 
South Korea 
Background: Although no-reflow detected by intracoronary myocardlal contrast 
echocardiography (IC-MCE) after primaiy coronary angioplasty in patients with acute 
myocardial infarction could predict a poor outcome of left ventricular function, clinical 
usefulness of intravenous myocardial contrast echocardiography (IV-MCE) for the evalu- 
ation of no-reflow remains to be elucidated. Methods: IC-MCE using Levovist injection, 
and IV-MCE using continuous infusion of PESDA (power Doppler mode, triggered inter- 
val 1:6) were performed for the evaluation of no-reflow immediately after percu:utaneous 
coronary intervention (Dl) of 22 patients with anterior wall acute myocardial infarction 
(age: 6029 yrs, 5 females). IV-MCE was repeated at the next day of the intervention 
(D2), and left ventricular ejection fraction (LVEF) and regional wall motion index (RWMI) 
were measured at D2 and 30 days later (D30). Data about MCE end other echocardio- 
graphic findings were analyzed independently. Results: There was a good agreement in 
determining no-reflow between IC-MCE and IV-MCE at Dl (kappa=0.72, pcO.005) as 
well as between IV-MCE at Dl and D2 (kappa=l.O, pcO.001). The patients with no-reflow 
on IC-MCE (n=lO) showed no improvement in LVEF (-0.6+4.2%. p=O.66) and RWMI (- 
0.06+0.09, p=O.lO) at D30 compared lo D2, while those with reflow on IC-MCE (n=l2) 
demonstrated significant improvement in LVEF (+6.8*6.3%, ~~0.005) and RWMI (- 
0.23iO.17, p<O.O05). The patients with no-reflow on IV-MCE at D2 (n=9) showed no 
improvement in LVEF (-1.2*3.8%, p=O.36) and RWMI (-0.05*0.08, p=O.l4) at D30 com- 
pared to D2, whereas those with reflow on IV-MCE at D2 (n=l3) demonstrated significant 
improvement in LVEF (+6.6*6.1%, p<O.O05) and RWMI (-0.22iO.17, p<O.OOl). Conclu- 
sion: IV-MCE at D2 could be substituted for IC-MCE performed immediately after the 
angioplasty for the evaluation of no-reflow and prediction of left ventricular systolic func- 
tion after 1 month in patients with anterior wall acute myocardial infarction. 
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1043-27 Diagnostic Accuracy of Myocardlal Perfusion by 
Sonazoid-Enhanced Ultraharmonic Imaging During 
Dipyridamole Stress Test 
Xiao-Fana Xu, Jeanne Drinko, Christine Whitman. Jianbao Li. Kathy Morris, Neil L 
Greenberg, James D. Thomas, The Cleveland Clinic Foundation, Cleveland, OH 
Background: We aimed to study the feasibility and accuracy of myocardial perfusion by 
Sonazoid-enhanced Ultraharmonic Imaging (UHI), in predicting significant coronary 
arlery disease. 
Methods 25 patients (63*12 years old; lam), with suspected coronary disease and no 
history of infarction, underwent MCE during dipyridamole stress lest. 3 apical views were 
acquired by UHI (Philip Sonos 5500; Ml 1.5; systolic triggered at sequential pulsing inter- 
vals at 1, 2, 4, 8 beats), during Sonazoid infusion (0.01 ul/kg/min). Myocardial perfusion 
was graded as normal, reversible, and fixed defect in 16 segments. All patients under- 
went coronary angiography. Coronary circulation was divided into two territories. LAD 
and RCAILCX. Agreement between 2 independent readers was determined by Kappa‘s 
coefficient of concordance (1~). Diagnostic value in predicting > 50% and ~70% Stenosis 
was ascertained. 
Results 17% (68/400) segments from MCE were not assessable due to artifacts. Agree- 
ment between two readers was 83% (z = 0.68). Table showed the diagnostic accuracy in 
predicting significant coronaiy stenosis (25pts, 50 territories). 
~50% stenosis >7o% etenoeis 
Sensitivity 74% 76% 
Specificity 67% 64% 
Positive predIcted value 87% 82% 
Negative predicted value 74% 77% 
Conclusions MCE pharmacological stress, using UHI and Sonazoid infusion, is feasible 
and accurate in detecting significant coronary stenosis. Large studies are needed 10 ver- 
ify this finding. 
